Additionally, Vastrad and Vastrad [98] found that IRX2 was downregulated in samples of diffuse GC, indicating that in both the intestinal and diffuse subtypes, the expression of IRX2 is altered. The gene discussed is IRX2; the disease is gastric cancer.